Old Web
English
Sign In
Acemap
>
authorDetail
>
Karen Siedlecki
Karen Siedlecki
Memorial Sloan Kettering Cancer Center
Prostate cancer
Medicine
Prostate-specific antigen
Radiology
Positron emission tomography
4
Papers
473
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and biologic activity of intravenous BCL-2 antisense oligonucleotide (G3139) and taxane chemotherapy in patients with advanced cancer.
2005
Applied Immunohistochemistry & Molecular Morphology
Michael J. Morris
Carlos Cordon-Cardo
William Kevin Kelly
Susan F. Slovin
Karen Siedlecki
Kevin Regan
Robert S. DiPaola
Mohamed M. Rafi
Neal Rosen
Howard I. Scher
Show All
Source
Cite
Save
Citations (25)
Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy.
2005
Clinical Cancer Research
Michael J. Morris
Tim Akhurst
Steven M. Larson
Marisa Ditullio
Elaina Chu
Karen Siedlecki
David Verbel
Glenn Heller
W. Kevin Kelly
Susan F. Slovin
Lawrence H. Schwartz
Howard I. Scher
Show All
Source
Cite
Save
Citations (111)
Phase I Trial of BCL-2 Antisense Oligonucleotide (G3139) Administered by Continuous Intravenous Infusion in Patients with Advanced Cancer
2002
Clinical Cancer Research
Michael J. Morris
William P. Tong
Carlos Cordon-Cardo
Marija Drobnjak
William Kevin Kelly
Susan F. Slovin
Kathryn L. Terry
Karen Siedlecki
Paul D. Swanson
Mohmed Rafi
Robert S. DiPaola
Neal Rosen
Howard I. Scher
Show All
Source
Cite
Save
Citations (162)
Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer
2002
Urology
Michael J. Morris
Timothy Akhurst
Iman Osman
Rodolfo Nunez
Homer A. Macapinlac
Karen Siedlecki
David Verbel
Lawrence H. Schwartz
Steven M. Larson
Howard I. Scher
Show All
Source
Cite
Save
Citations (175)
1